Publications by authors named "Mark Berger"

Claim this Profile
D
Dose Escalation Trial of the Combination of Osimertinib and Quaratusugene Ozeplasmid Gene Therapy in Patients with Advanced NSCLC.
Alexander I Spira, David Berz, Robert M Jotte, Krishna K Pachipala, Mark S Berger

Clin Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allele-specific expression reveals genetic drivers of tissue regeneration in mice.
Katya L Mack, Heather E Talbott, Michelle F Griffin, Jennifer B L Parker, Nicholas J Guardino, Mark J Berger

Cell Stem Cell· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-radiation conjugates for acute myeloid leukemia: an interview with Mark Berger.
Mark S Berger

Future Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance elastography vs. point shear wave ultrasound elastography for the assessment of renal allograft dysfunction.
Paul Kennedy, Octavia Bane, Stefanie J Hectors, Sonja Gordic, Mark Berger

Eur J Radiol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy.
Wojciech Dawicki, Kevin J H Allen, Ravendra Garg, Eileen M Geoghegan, Mark S Berger

Oncotarget· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance elastography vs. point shear wave ultrasound elastography for the assessment of renal allograft dysfunction.
Paul Kennedy, Octavia Bane, Stefanie J Hectors, Sonja Gordic, Mark Berger

Eur J Radiol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Employer-mandated obstructive sleep apnea treatment and healthcare cost savings among truckers.
Stephen V Burks, Jon E Anderson, Bibhudutta Panda, Rebecca Haider, Tim Ginader, Mark Berger

Sleep· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pre-Registry Commercial Driver Medical Examination: Screening Sensitivity and Certification Lengths for Two Safety-Related Medical Conditions.
Stephen Vincent Burks, Jon Eugene Anderson, Bibhudutta Panda, Humza Syed Haider, Rebecca Haider, Mark Berger

J Occup Environ Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell transcriptional diversity is a hallmark of developmental potential.
Gunsagar S Gulati, Shaheen S Sikandar, Daniel J Wesche, Anoop Manjunath, Anjan Bharadwaj, Mark J Berger

Science· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Color Data v2: a user-friendly, open-access database with hereditary cancer and hereditary cardiovascular conditions datasets.
Mark J Berger, Hannah E Williams, Ryan Barrett, Anjali D Zimmer, Wendy McKennon

Database (Oxford)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab-Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumors.
Wojciech Dawicki, Kevin J H Allen, Rubin Jiao, Mackenzie E Malo, Muath Helal, Mark S Berger

Oncoimmunology· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic Level.
Alp Tuna Beksac, Shivaram Cumarasamy, Ugo Falagario, Paige Xu, Mandeep Takhar, Mark Berger

J Urol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independent erosion of conserved transcription factor binding sites points to shared hindlimb, vision and external testes loss in different mammals.
Mark J Berger, Aaron M Wenger, Harendra Guturu, Gill Bejerano

Nucleic Acids Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10.
Alexandra Zanin-Zhorov, Jonathan M Weiss, Alissa Trzeciak, Wei Chen, Jingya Zhang, Mark Berger

J Immunol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity.
Karthik A Jagadeesh, Aaron M Wenger, Mark J Berger, Harendra Guturu, Peter D Stenson

Nat Genet· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonadherence with Employer-Mandated Sleep Apnea Treatment and Increased Risk of Serious Truck Crashes.
Stephen V Burks, Jon E Anderson, Matthew Bombyk, Rebecca Haider, Derek Ganzhorn, Mark Berger

Sleep· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma.
André Goy, Mark Berger, Peggy Ford, Tatyana Feldman, Anthony Mato

Leuk Lymphoma· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma.
André Goy, Francisco J Hernandez-Ilzaliturri, Brad Kahl, Peggy Ford, Ewelina Protomastro, Mark Berger

Leuk Lymphoma· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II, multicenter, open-label study of obatoclax mesylate in patients with previously untreated myelodysplastic syndromes with anemia or thrombocytopenia.
Martha L Arellano, Gautam Borthakur, Mark Berger, Jill Luer, Azra Raza

Clin Lymphoma Myeloma Leuk· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer.
Corey J Langer, Istvan Albert, Helen J Ross, Peter Kovacs, L Johnetta Blakely, Mark S Berger

Lung Cancer· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancer.
Alberto Chiappori, Charles Williams, Donald W Northfelt, John W Adams, Shakun Malik, Mark S Berger

J Thorac Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Portable diagnostic devices and commercial motor vehicle drivers.
Chunbai Zhang, Mark Berger, Atul Malhotra, Stefanos Kales

Sleep· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Portable diagnostic devices for identifying obstructive sleep apnea among commercial motor vehicle drivers: considerations and unanswered questions.
Chunbai Zhang, Mark Berger, Atul Malhotra, Stefanos N Kales

Sleep· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Employer-mandated sleep apnea screening and diagnosis in commercial drivers.
Mark Berger, Vasileia Varvarigou, Albert Rielly, Charles A Czeisler, Atul Malhotra

J Occup Environ Med· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Like raising a child.
Mark S Berger

J Clin Oncol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis